Market Cap (In USD)
1.67 Million
Revenue (In USD)
1.55 Million
Net Income (In USD)
-10.81 Million
Avg. Volume
3737.00
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 9.0E-4-0.1076
- PE
- -
- EPS
- -
- Beta Value
- 0.772
- ISIN
- AU000000AC89
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mr. Christopher Mews A.C.I.S., B. Bus, C.P.A.
- Employee Count
- -
- Website
- https://auscann.com.au
- Ipo Date
- 2017-02-10
- Details
- AusCann Group Holdings Ltd does not have significant operations. Previously, it was engaged in the researches, develops, and commercializes various cannabinoid-derived therapeutic products. The company is headquartered in West Perth, Australia.
More Stocks
-
MANKINDMankind Pharma Limited
MANKIND
-
RCC
-
KHNGF
-
IMCCIM Cannabis Corp.
IMCC
-
ZONE
-
5289Innodisk Corporation
5289
-
VICA
-
OXY-WT